In heart assist devices, the small stuff matters. Details like contact electrical resistance in the power interconnect can have a big impact on device life and patient safety. The Bal Conn® electrical contact and SYGNUS® implantable contact system (a turnkey serial Bal Conn® and silicone seal configuration) offer ultra-low contact resistance of <10 milliohms...
In this session, originally presented on August 6, 2020 during the TechTalk segment of Informa’s BIOMEDevice virtual show, Bal Seal Engineering Business Development Director David Fogel talks about how components (including seals, springs, and contacts) represent “hidden opportunities” for performance improvement in surgical robot designs. He explores how they can be leveraged to...
Designing cardiac rhythm management and ventricular assist devices that reliably deliver lifesaving therapy is a tough job. But choosing the right electrical contact can make it a lot easier. That’s why we’ve prepared this short presentation for you. It examines the relationship between electrical contact selection and the performance of cardiac devices. It...
Implanted in the body, cardiac devices manage and monitor pacing, assist with ventricular pumping, and defibrillate the heart through the use of electrical pulses. Device lead interconnects must safely and reliably link the battery and electronics to the lead. Designs must support strict standards for implantables (IS-1, IS-4,, or DF-4), as well as VAD...
Our Bal Conn® electrical contact helps manufacturers of implantable medical devices improve performance while reducing package size and increasing reliability. Download our white paper to learn more.
In the world of medical electronics, the title for biggest breakthrough goes to closed loop functionality. This technological milestone has helped device designers achieve new levels of active implantable performance, and it has driven change in three crucial areas: power conservation (providing stimulation only as needed through neural feedback), improved patient efficacy (adjusting therapy...
Systemization reduces time to market. For years, manufacturers of neurostimulators and other active implantables have been feeling extraordinary pressure from shareholders and other funding sources to move more quickly from design stage to production. As a result, many device makers have begun searching for opportunities to integrate components as subsystems in order to...
SYGNUS is the world’s first integrated seal and electrical contact system for active implantable devices. It is engineered to help large and small device OEMs accelerate the development process and dedicate valuable resources to therapy and function improvements, instead of component procurement and testing. Find out more from this video and by visiting us...
